Vicarious Surgical Inc. (RBOT): R&D Expense

Annual figures by period end, from SEC filings.

$33.60M
Year ended 2025-12-31
-8.5%
3-year compound annual growth
+28.0%
5-year compound annual growth
$47.58M2020-12-31: $9.80M2021-12-31: $22.06M2022-12-31: $43.90M2023-12-31: $47.58M2024-12-31: $40.16M2025-12-31: $33.60M$33.60M
2020-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$33.60M-16.3%2026-03-09, From 2025-01-01
2024-12-31$40.16M-15.6%2026-03-09, From 2024-01-01
2023-12-31$47.58M+8.4%2025-03-17, From 2023-01-01
2022-12-31$43.90M+99.0%2024-03-04, From 2022-01-01
2021-12-31$22.06M+125.2%2023-02-15, From 2021-01-01
2020-12-31$9.80Mn/a2022-03-31, From 2020-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Vicarious Surgical Inc. (RBOT)2025-12-31$33.60M-16.3%
Safe Pro Group Inc. (SPAI)2025-12-31$394.2K+336.2%
LogicMark, Inc. (LGMK)2025-12-31$617.4K+10.5%
Lifeward Ltd. (LFWD)2025-12-31$3.25M-29.8%
Anteris Technologies Global Corp. (AVR)2025-12-31$69.12M+34.3%
CollPlant Biotechnologies Ltd (CLGN)2025-12-31$8.19M-22.1%
Myomo, Inc. (MYO)2025-12-31$6.94M+45.5%
ENvue Medical, Inc. (FEED)2025-12-31$1.76M+93.8%
Envoy Medical, Inc. (COCH)2025-12-31$12.49M+22.7%

Compare RBOT, SPAI, LGMK, LFWD side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗